Plain-English translation of NCT03625739 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Researchers are studying how anti-tuberculosis drugs work in children's bodies by collecting blood samples and measuring medicine levels. The goal is to create a math-based model that shows how different children's bodies handle these medicines differently, so doctors can prescribe the right dose for each individual child. Then the researchers will test whether using these personalized doses works better and safer than the standard one-size-fits-all approach.
Standard tuberculosis medicine doses work for many children, but not all children's bodies process these medicines the same way—some may need more medicine, others less. By understanding how individual children's bodies handle this medication, doctors could potentially cure tuberculosis faster and with fewer side effects.
You likely qualify if…
You likely don't qualify if…
If you join the first part of this study, you will have blood samples collected at different times after taking your tuberculosis medicine—researchers need samples from about 100 children per medicine to measure how much drug is in your bloodstream. If you're selected for the second part, you may receive personalized doses of your medicine based on the study's findings, and researchers will compare how well you do compared to children receiving standard doses, checking your treatment response, liver and kidney function, and any side effects.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
China